Senators Seek Further Information About Federal Efforts to Facilitate Medical Marijuana Research

by Press on December 21, 2015

Press Author

More in Health and Fitness:

MakeMyTestCount.org: NIH Establishes Website For Self-Reporting COVID-19 Test Results November 22, 2022
Extended Medicaid Coverage for Postpartum Care in Year-End Funding Bill: Rep. Robin Kelly Leads the Call September 22, 2022
Rep. Kelly’s Bipartisan Reese’s Law Passes the Senate, Heads to President Biden’s Desk for Signing August 4, 2022

Follow-up letter comes after federal agency response leaves unanswered questions about efforts to address regulatory barriers to critical research
Washington, DC --(ENEWSPF)--December 21, 2015. United States Senators Elizabeth Warren (D-Mass.), Barbara Mikulski (D-Md.), Barbara Boxer (D-Calif.), Ron Wyden (D-Ore.), Jeff Merkley (D-Ore.), Kirsten Gillibrand (D-N.Y.), Edward J. Markey (D-Mass.), and Cory Booker (D-N.J.) sent a follow-up letter to the U.S. Department of Health and Human Services (HHS), the Office of National Drug Control Policy (ONDCP), and the Drug Enforcement Administration (DEA) seeking additional information about the . . .